Archive | Clinical Trials

Dual Immunotherapy a Winner for Melanoma Brain Mets

Combined immunotherapy with two checkpoint inhibitors…

Read the full story

Posted in Melanoma News, Clinical Trials

Combination immunotherapy shrinks melanoma brain metastases

Combination immunotherapy shrank melanoma that has spread to the brain in more than half of the patients in a clinical trial…

Read the full story

Posted in Melanoma News, Clinical Trials

Combination Approach Shows Promise For Beating Advanced Melanoma

Source: ScienMag, September 2018 A UCLA-led study has found that a treatment that uses a bacteria-like agent in combination with an immunotherapy drug could help some people with advanced melanoma, an aggressive form of skin cancer, live longer. The research showed that using the immunotherapy drug pembrolizumab and the experimental agent SD-101, a sequence of […]

Read the full story

Posted in Melanoma News, Clinical Trials

Adjuvant bevacizumab not recommended for melanoma, HER2-negative breast cancer

medwireNews: The AVAST-M and E5103 trial results rule out the use of bevacizumab in the adjuvant setting in high-risk patients with cutaneous melanoma and HER2-negative breast cancer, respectively.

Read the full story

Posted in Melanoma News, Clinical Trials